Colon and Rectal Cancer Drugs Market Continues to Grow as Bristol-Myers Squibb Partners with Bayer AG to test Opdivo and Stivarga in patients with microsatellite stable metastatic colorectal cancer
Colorectal Cancer is the medical name for cancer that occurs in the rectum or colon, which in combination with its numerous other names makes up the large intestines. Colon cancer, among the most prevalent cancers in America, accounts for more than half of all cancers diagnosed in the U.S. As a result, the treatment and outcomes of this debilitating disease can greatly affect your quality of living. The difficulty of detecting colorectal cancer contributes greatly to the difficulty of treating it. For this reason, many doctors will try to remove any polyps and tumor that they are able to discover through surgical techniques only to find that the cancer had re-appeared later at an even more advanced stage. Increasing incidence of colorectal cancer is expected to drive growth of the global colon and rectal cancer drugs market. According to the American Society of Clinical Oncology (ASCO), colorectal cancer is the third most common cancer diagnosed in both men and women in the U.S. Acco...